Developing an Ebola Vaccine and Taking it to Clinical Trials

Waisman Center Information Session & Panel Discussion

• Download a PDF of this flier

Information Session:

Yoshihiro Kawaoka, PhD

Professor, Department of Pathobiological Sciences
School of Veterinary Medicine
University of Wisconsin-Madison

Yoshihiro Kawaoka will give a brief presentation about a promising Ebola vaccine developed in his lab using a technology called Delta VP30. The vaccine will soon be produced by Waisman Biomanufacturing for clinical trials.

The presentation will be followed by a panel discussion and Q & A session with scientists and biosafety experts from the Waisman Center and UW–Madison.

Panel Discussion:

Bill MacLean (moderator)
Interim Director
Waisman Center

Yoshihiro Kawaoka
Professor
School of Veterinary Medicine

Carl Ross
Managing Director
Waisman Biomanufacturing

Rebecca Moritz
Select Agent Program Manager
Environment, Health & Safety

Alhaji N’jai
Research Fellow
School of Veterinary Medicine

Related:

• Ebola Vaccine Inches Toward Human Clinical Trials
• Ebola vaccine (Delta VP30) FAQ